Cell-free Assays (IC50/Ki) for EPZ-6438 (Tazemetostat)
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| No published data available. | |||
Cell-based Assay (IC50) for EPZ-6438 (Tazemetostat)
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| PBMCs from patients with HAM | 214.2 nM | Cell proliferation assay | Download PDF |
| Pt3R cells | 79.81 ± 4.91 μM | CCK8 assay | Download PDF |
| G401 (rhabdoid tumor cell line) | > 100 mM | Cell viability assay | Download PDF |
| A204 (rhabdoid tumor cell line) | > 100 mM | Cell viability assay | Download PDF |
| VA-ES-BJ (epithelioid sarcoma cell line) | > 100 mM | Cell viability assay | Download PDF |
Check the
EPZ-6438 (Tazemetostat)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- EPZ-6438 (Tazemetostat) Mechanism of Action: EZH2 Inhibition in B-Cell Research
- EPZ-6438 (Tazemetostat) Clinical Trials
- EPZ-6438 (Tazemetostat) Working Concentration | Cell Culture | Treatment
- EPZ-6438 (Tazemetostat) Solubility in DMSO
- EPZ-6438 (Tazemetostat) Stock Solution
- EPZ-6438 (Tazemetostat) Storage
- EPZ-6438 (Tazemetostat) Stability
- EPZ-6438 (Tazemetostat) VS GSK126 | 3-Deazaneplanocin A (DZNep) Hydrochloride
- EPZ-6438 (Tazemetostat) Molecular Weight
- EPZ-6438 (Tazemetostat) SMILES
- EPZ-6438 (Tazemetostat) CAS Number
- EPZ-6438 (Tazemetostat) Chemical Structure (2D and 3D)
- EPZ-6438 (Tazemetostat) Sigma (SBR00098)? Try a better option.
- EPZ-6438 (Tazemetostat) MedChemExpress (HY-13803)? Try a better option.
- EPZ-6438 (Tazemetostat) Cayman (16174)? Try a better option.
- EPZ-6438 (Tazemetostat) Tocris (8093)? Try a better option.
- EPZ-6438 (Tazemetostat) TargetMol (T1788)? Try a better option.
- EPZ-6438 (Tazemetostat) SDS｜MSDS